ARCHIVES

Drugs and Targets: EU approves Imbruvica in MCL, CLL

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

Final Issue of 1981

December 11, 1981

Tumor Classification, Monoclonal Antibody Announcements Made

January 7, 1983

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

August 8, 1980

SWOG Trial Reports Longest Survival To Date For NSCLC

June 29, 2001

Health Association Oppose U.S. Trade Policy On Tobacco Exports; Recommend Restrictions

August 25, 1989

Kramer Says New Radiotherapy Could Save 1.3 Of Failures

February 18, 1977